Rowatinex drops are used for the prevention and treatment of urinary lithiasis. Adjuvant in the treatment of mild-moderate urinary tract infections and nephropathies.
Ingredients: 100g oral drops, solution containing alpha-pinem 24.8 g, beta-pineme 6.2 g, campene 15 g, cineole 3 g, fencone 4 g, borneol 10 g and anethole 4 g and excipient, olive oil. Pharmacotherapeutic group for Rowatinex: other urologic products, urinary antispasmodics.
How to use:
Adults – The usual dose is 3-5 oral drops, Rowatinex solution 4-5 times a day, 30 minutes before meals or as recommended by the doctor. On the doctor’s recommendation, during very painful periods, especially if colic pain occurs, a dose of 20-30 oral drops, Rowatinex solution, is administered, which can be repeated after 15-20 minutes if necessary or up to 40 oral drops, in a single dose.
Children aged 6 to 14 years – The usual dose is 1–2 oral drops, Rowatinex solution 3–4 times a day, 30 minutes before meals or as recommended by the doctor.
Side effects for Rowatinex – Occasionally, mild and transient gastric disturbances have been reported. Rarely, vomiting has been reported. Two mild cases of drug intolerance have been reported. Allergic reactions may occur, even delayed.
Overdose – in case of overdose, gastric irritation with nausea, vomiting and diarrhea may occur. If the drug has been swallowed for a short time, gastric lavage will be performed. The patient should be carefully monitored and, if necessary, symptomatic treatment should be instituted. Cardiac, respiratory, renal and hepatic function should be monitored. Toxicological studies in animals have shown that high doses of essential oils can cause depression of the central nervous system to the point of excitement and seizures.
Do not use after the expiry date stated on the package. Do not store below 25 degrees Celsius in the original packaging. Keep out of reach of children.
Special warnings: In patients with renal colic, medical supervision of the treatment is recommended. Pregnancy and breastfeeding. Although no teratogenic effects have been reported, Rowatinex should not be administered in the first trimester of pregnancy. As insufficient information is available, Rowatinex should not be given to breastfeeding women. Rowatinex does not affect the ability to drive or use machines.
Contraindications: Severe renal colic, anuria, serious urinary tract infections, urinary lithiasis requiring surgical treatment.
Interactions: Caution should be exercised in patients treated with anticoagulants or other hepatically metabolised medicinal products that have a low therapeutic index.
Presentation form: 10ml bottle
Reviews
There are no reviews yet.